New Delhi: To speed up vaccination in the country, the anti-corona vaccine manufactured abroad has now been approved for import into India. Vaccines that have been approved by the US, UK, Japan, Europe’s regulators, and the WHO for emergency use will also be approved for use in India. NITI Aayog member Dr. V.K. Paul gave this information on Wednesday.
Currently, 3 vaccines have been approved in India including Covaxin of Bharat Biotech, Covishield of Serum Institute and Sputnik V manufactured in Russia. Which vaccine will be available in India in the future after this decision of the government.
- Pfizer-BIONTECH Vaccine: The Pfizer vaccine is up to 95% effective, with two doses to be applied at an interval of 21 days. To store it, a temperature of minus 25 to minus 15 degrees is required. Its price in the international market is around ₹ 1500. However, before its use in India, there will be a discussion about its price.
- Moderna Vaccine: Moderna vaccine is up to 94.1% effective, it will have to be administered in two doses at an interval of 28 days. A temperature of 2 to 8 degrees is required to store it. The price of one dose of this in the international market is around ₹ 1800.
- johnson and johnson’s Janssen vaccine: Talking about the efficiency rate of the Janssen vaccine, this single-dose vaccine is 66.3% effective. A temperature of 2 to 8 degrees is required to store it. Although its price is lower than other vaccines, the price of one dose is around ₹ 750.
- Novavax Vaccine: Protein-based vaccine Novavax has an efficiency rate of around 90%. It requires a temperature of 2 to 8 degrees to store it and its price in the US is around ₹ 1200.
- Sputnik V: Sputnik V of Russia has got the approval to use Emergency in India. According to the Russian agency RDIF, Sputnik is a vaccine with 91.6% efficacy, which can be stored at a temperature of 2 to 8 ℃. One of its doses is less than $ 10, which is less than about Rs 750.
According to the WHO, there are 200 additional vaccines in operation worldwide, of which 60 are in the clinical development phase. The world’s largest vaccination campaign is being conducted in India, and so far more than 11 crore vaccine doses have been given. Vaccine made in foreign countries can give further impetus to vaccination in India.